umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
EGFR tyrosine kinase inhibitors in non-small cell lung cancer: Nationwide register-based cohort study in Sweden
Umeå University, Faculty of Medicine, Department of Radiation Sciences.ORCID iD: 0000-0003-1351-5153
2018 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 29, p. 526-526Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford University Press, 2018. Vol. 29, p. 526-526
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-157241DOI: 10.1093/annonc/mdy292.076ISI: 000459277303224OAI: oai:DiVA.org:umu-157241DiVA, id: diva2:1297007
Conference
43rd ESMO Congress (ESMO), Munich, Germany, 19-23 October, 2018
Note

Supplement 8

Meeting abstract 1454P

Available from: 2019-03-18 Created: 2019-03-18 Last updated: 2019-03-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Bergqvist, Michael

Search in DiVA

By author/editor
Bergqvist, Michael
By organisation
Department of Radiation Sciences
In the same journal
Annals of Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 39 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf